The objective of this study was to develop and test a combined therapeutic approach for patients with AIDS-related lymphoma (ARL), employing agents with independent mechanisms of action and nonoverlapping toxicity. This study was designed to test the feasibility and tolerance of combining low dose c
Pharmacokinetic profile of Mitoguazone (MGBG) in patients with AIDS related non-Hodgkin's lymphoma
β Scribed by Jinee Rizzo; Alexandra M. Levine; Geoff R. Weiss; Tillman Pearce; Maura Kraynak; Robert Mueck; Susan Smith; Daniel D. Hoff; John G. Kuhn
- Publisher
- Springer US
- Year
- 1996
- Tongue
- English
- Weight
- 697 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Although cardiac involvement has been commonly described in HIV-infected patients, cardiac tamponade is an unusual feature of AIDS-related non-Hodgkin's lymphoma. We describe an AIDS patient with undiagnosed non-Hodgkin's lymphoma presenting with hemodynamics of pericardial tamponade.
The causes of death and postmortem findings in patients treated for non-Hodgkin's lymphoma at a single institution over a 13-year period were reviewed. Postmortem examination (70% of the entire sample) revealed evidence of lymphoma in 67 of 80 patients. The most frequent extranodal sites of involvem
## Abstract Highly active antiretroviral therapy (HAART) became available in the US in 1996. Using the populationβbased cancer registry, we identified 233 patients with AIDSβrelated systemic NHL diagnosed in San Diego or Orange County in 1994β1999, of whom 137 were diagnosed 1996β1999. We performed
Background: the overall outcome of patients with HIV-related non-Hodgkin's lymphomas (HIV-NHL) is poor because of the adverse clinico-pathological features of HIV-NHL and of the underlying HIV infection. However, the experience of physicians in the management of HIV-NHL has increased, in particular